Contract numberBOA 26389-001-01 48icpt.goe/agreements/alphabetical/hewlett-packard-enterprise-hpe/ Any U.S. Federal Department of Energy laboratory prime contract holder is eligible to purchase under the ICPT issued blanket puraseching order agreements. Any DOE Laboratory Prime Contractor can purchase from a licensed HPE ICPT dealer. The latest ICPT partners and their corresponding accounts are listed in the other tab. Computer Products:Serveurs, Storage and Network Equipment, Software and Support For general questions about ICPT, please contact a member of the ICPT Executive Steering Council. Monitoring strategic procurement opportunities that represent procurement expenditures, resulting in lower overall operating costs for DOE Complex Wide Site and Facility Contractors; Strategic Partnership Projects (SPP) Cost Audit and Testing Services (NAICS Code 541211 – Offices of Certified Public Accountants) The HPE DOE sales team is ready to assist you every step of the way. Please contact our DOE sales team under the numbers below or preferably contact your HPE ICPT partner on site. Army combat uniforms, various equipment related to the security supply of gas cylinders on a base adapted to the needs, which are required the highest purity, quality and quantity. DOE sites with assigned authorized HPE ICPT resellers can order directly from the dealer. ICPT HPE resellers are authorized to provide BOA price offers, product specifications and general information.

You also have the right to accept orders as part of this BOA. Orders placed by the dealer must be sent directly to the dealer. This website provides basic order agreements (BOA) negotiated by ICPT or DOE for use by site and facility providers and eligible subcontractors. If you have any questions about a particular BOA, please contact the relevant contract administrator. Westwind is an ICPT vehicle agent in partnership with HPE. Intercept Pharmaceuticals, Inc. is a biopharmaceutical company that conducts research, development and commercialization of new therapeutic drugs in the treatment of chronic liver disease. Its product pipeline is OCALIVA, which is used for the treatment of primary bile helangitis, the most non-alcoholic steatohepatitis, primary sclerosing cholangitis and bile resistance. The company was founded on September 4, 2002 by Mark E. Pruzanski and Roberto Pellicciari and is headquartered in New York, NY. Make a list of the investments you want to follow. Tom Wiewiora, 1-630-728-45434Mail Tom Wiewiora Mon Parab, 1-408-623-9514Mail Monish Parab The complex agreements used by Sandia include: The Royal Society of Chemistry Subscription Agreements for Access to Subscribed Products.

Visit an offer page and your latest tickers are displayed here.